AHA 22 - Dr Rawan Amir, CardioNerds Fellow (Johns Hopkins Hospital, US) joins us in this collaboration between the @CardioNerds and Radcliffe Cardiology to interview Dr Paul Kalra (Portsmouth Hosp Univ NHS Trust, UK), investigator of the late-breaking IRONMAN trial (NCT02642562).
This randomised, open-label multicentre trial assessed the effectiveness of intravenous iron treatment compared to standard care in patients with heart failure and iron deficiency.
The trail demonstrated that in a broad range of patients with heart failure, a reduced LVEF and iron deficiency, administration of IV FDI was associated with a lower risk of recurrent heart failure hospitalizations and CV death, which approached statistical significance.
Access our full AHA 22 Scientific Coverage here.
Recorded remotely from Portsmouth and Baltimore, 2022.
Editor: Mirjam Boros
Video Specialist: Oliver Miles